Engineered Toxin Bodies Targeting CD38 in Myeloma with Shaji Kumar, MD, Mayo Clinic

A new treatment called Engineered Toxin Bodies (ETBs) with a stronger mechanism of action is being developed by Molecular Templates.

Posted by

HealthTree

The 2026 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center

Learn about what's here and what's coming in 2026 in multiple myeloma care with myeloma expert Robert Orlowski, MD, PhD

Posted by

HealthTree

Myths vs. Facts about Diet in Multiple Myeloma

Listen to this episode where Dr. Urvi Shah will talk about the myths and facts about food and how our diet impacts our outcomes on our myeloma journey

Posted by

HealthTree

A Look into the 2025 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center

Learn about what's here and what's coming in 2025 in multiple myeloma care with myeloma expert Robert Orlowski, MD, PhD

Posted by

HealthTree

Tasquinimod As a New Myeloma Therapy with Dan Vogl, MD and Yulia Nefedova, MD, PhD

In this show, Dr. Vogl and Dr. Nefedova teach us what MDSCs are and how they work and how a new therapy called tasquinimod could help slow down myeloma growth.

Posted by

HealthTree

Minimal Residual Disease (MRD) Testing with Dr. Rafael Fonseca

Join Rafael Fonseca, MD, Mayo Clinic to learn when MRD testing should be done and how the results should be used in myeloma care.

Posted by

HealthTree

The 2024 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center

Learn about what's here and what's coming in 2024 in multiple myeloma care with myeloma expert Robert Orlowski, MD, PhD

Posted by

HealthTree

The Future of Bispecific Antibodies with Dr. Philippe Moreau

Dr. Moreau will provide a review of approved and in-development bispecific antibodies, side effect management and more.

Posted by

HealthTree

Preventing Myeloma Progression with Diet: The Nutrivention-2 Study

Join Dr. Urvi Shah to discuss how diet can prevent myeloma progression and learn about the Nutrivention-2 study.

Posted by

HealthTree